CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51 | +24.4% | 22,317 | +92.6% | 0.00% | – |
Q1 2023 | $41 | -99.9% | 11,586 | -29.4% | 0.00% | – |
Q3 2022 | $36,000 | -18.2% | 16,400 | -8.0% | 0.00% | – |
Q2 2022 | $44,000 | +238.5% | 17,820 | +532.6% | 0.00% | – |
Q1 2022 | $13,000 | -90.0% | 2,817 | -75.6% | 0.00% | – |
Q4 2021 | $130,000 | +44.4% | 11,535 | +55.6% | 0.00% | – |
Q3 2021 | $90,000 | +13.9% | 7,411 | +8.8% | 0.00% | – |
Q2 2021 | $79,000 | -34.7% | 6,811 | -31.3% | 0.00% | – |
Q1 2021 | $121,000 | +1110.0% | 9,921 | +2124.4% | 0.00% | – |
Q2 2020 | $10,000 | -23.1% | 446 | -54.7% | 0.00% | – |
Q1 2020 | $13,000 | – | 984 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |